Top Markets
#1 PulseChain PulseChain +43.68%
#2 Bitway Bitway +9.47%
#3 Fake World Assets Fake World Assets +8.69%
#4 eCash eCash +7.79%
#5 Not in Employment, Education, or Training Not in Employment, Education, or Training +7.28%
#6 Meteora Meteora +6.01%
#7 EthereumPoW EthereumPoW +5.75%
#8 Velvet Velvet +5.32%
#9 Bitcoin SV Bitcoin SV +5.29%
#10 Creditcoin Creditcoin +5.17%
Coin of the day
PulseChain PulseChain
Settings
Language
ENGLISH
Currency
USD
Theme
Meribank Biotech Co., Ltd Meribank Biotech Co., Ltd

Meribank Biotech Co., Ltd

4724
Rank in Stocks #28402
Meribank Biotech Co., Ltd, established in 2013 and headquartered in Taipei... Meribank Biotech Co., Ltd, established in 2013 and headquartered in Taipei City, Taiwan, is a company dedicated to the cultivation, advancement, and banking of mesenchymal stem cells. The firm specializes in the preservation of various cell types, including mesenchymal stem cells sourced from the placenta and umbilical cord, hematopoietic stem cells from cord blood, and diverse immune cells. Additionally, Meribank is involved in developing advanced cellular cryopreservation protocols and provides postpartum nursing services.
Share Price
$0.2779235
Last synced: 2026-08-19
Market Cap
$26.67M
Change (1 day)
1.39%
Change (1 year)
-50.33%
Country
TW
Trade Meribank Biotech Co., Ltd (4724)

Category

Healthcare
P/E ratio for Meribank Biotech Co., Ltd (4724)
P/E ratio as of 2026 TTM: 0
According to Meribank Biotech Co., Ltd latest financial reports and stock price the company's current price-to-earnings ratio (TTM) is 0. At the end of 2026 the company had a P/E ratio of 0.
P/E ratio history for Meribank Biotech Co., Ltd from 2026 to 2026
P/E ratio at the end of each year
Year P/E Ratio Change
Not enough data for the provided dates.
P/E ratio for similar companies or competitors
Company P/E Ratio P/E Ratio Difference Country
Vertex Pharmaceuticals Incorporated Vertex Pharmaceuticals Incorporated
Vertex Pharmaceuticals Incorporated
VRTX.US
 29.20 -
US
Moderna, Inc. Moderna, Inc.
Moderna, Inc.
MRNA.US
 -7.93 -
US
Argenx SE Argenx SE
Argenx SE
ARGX.US
 30.62 -
NL
CSL Limited CSL Limited
CSL Limited
CSL.AX
 32.46 -
AU
Lonza Group AG Lonza Group AG
Lonza Group AG
LONN.SW
 - -
CH
How to read a P/E ratio?

The Price/Earnings ratio measures the relationship between a company's stock price and its earnings per share.
A low but positive P/E ratio stands for a company that is generating high earnings compared to its current valuation and might be undervalued. A company with a high negative (near 0) P/E ratio stands for a company that is generating heavy losses compared to its current valuation.

Companies with a P/E ratio over 30 or a negative one are generaly seen as "growth stocks" meaning that investors typically expect the company to grow or to become profitable in the future.

Companies with a positive P/E ratio bellow 10 are generally seen as "value stocks" meaning that the company is already very profitable and unlikely to strong growth in the future.